ValuentumAd

Official PayPal Seal

Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Mar 16, 2017
The “Year of Evangeline Adams” Continues
"...the S&P 500 has advanced more than 250% since the March 2009 panic bottom when it closed at 676.53 on the 9th of the month. Today, March 15, 2017, it closed at 2,385.26. The performance represents “a triple and then some” in the 8 years of this aging bull market. This is not performance on speculative small caps or risky biotechs, but on the largest companies in America. Please exercise prudence and care in all that you do." -- Brian Nelson, CFA
Mar 2, 2017
Dow 21,000+; Forward P/E on S&P 500 ~18!!!
To say that the broader equity market is “extended” is an understatement.
Feb 27, 2017
Dividend Increases/Decreases for the Week Ending February 24
Let's take a look at companies raising/lowering their dividends this week.
Feb 14, 2017
Is AbbVie a Value Trap?
Image Source: Express Scripts. With uncertainty surrounding the patent of blockbuster drug Humira, AbbVie is looking to deliver another success story from its pipeline. Is it headed for a patent cliff? Let’s take a look.
Feb 6, 2017
Dividend Increases/Decreases for the Week Ending February 3
Let's take a look at companies raising/lowering their dividends this week.
Feb 4, 2017
The Bottom Line: Altria’s Translates to Dividend Growth
Image Source: Peyri Herrera. Altria continues to successfully battle a challenging demand environment for cigarette volumes across its industry, and the company has once again rolled out expectations for meaningful earnings-per-share growth in 2017. Altria’s stock is among the best performers in history – find out why.
Jan 18, 2017
Kinder Morgan Continues to Chop Down Its Debt Load
Image Source: Loren Kerns. Kinder Morgan continues to hover around our ~$20 fair value estimate for shares as the pipeline giant works to get its financial house in order.
Jan 15, 2017
The Coming “Goldman Sachs Era”
Image Source: Jussi. Valuentum covers recent developments in the financials sector, including hopes for a relaxation of certain prohibitive Dodd-Frank rules that, if repealed, could pave the way for improved economic returns across the banking sector during the Trump administration. A look back at the month of September 2008, and how Goldman Sachs may very well shape the financial markets during the next few years are two other areas in the piece. Financials stocks have come roaring back since Trump was elected the 45th President of the United States. We've participated.
Jan 10, 2017
Teva’s Near-17% Free Cash Flow Yield; Is The Bottom Finally In?
Image Source: Teva. What a roller coaster ride in Teva’s shares. After converging to intrinsic value, Teva’s shares have fallen from grace. Unfortunately, our excitement over this big winner has turned to agony. But is the bottom finally in? What has happened in the past is now behind us, and we have to continue to look forward with respect to our analysis of shares.
Jan 1, 2017
Dividend Growth Newsletter: Evaluating Our 2016 Dividend Growth Picks
What say us of our dividend growth stock-selection skills?



The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.